Senior Burnet researchers selected for prestigious AAHMS mentoring program
Improved maternal health outcomes in Burnet modelling for Gates Foundation
Burnet researchers receive $5 million in NHMRC grants
UN High Level Meeting a prime opportunity to end TB
Research Reports + Policy Briefs
IMPACT Magazine
Events
Research Articles
How Science Matters Podcast
Study at Burnet
"It is still very little; I cannot pass it on": a qualitative study of experienc...
Police drug seizures cannot solve the problem of toxic drug supply in North Amer...
The unfinished agenda of communicable diseases among children and adolescents be...
Robust immunity to influenza vaccination in haematopoietic stem cell transplant ...
Vaccines
Diagnostics
Therapeutics
Antibody Platforms
Australia
Papua New Guinea
Myanmar
People of Burnet
Leadership
Burnet Partners
Board Members
Current Appeal
Donating for Individuals
Trusts + Foundations
Corporate Supporters
Giving in Wills + Bequests
Supporter Stories
About Us
Careers
History
Annual + Financial Reports
Explore our research reports and policy briefs, designed to explain key findings of our work clearly and provide recommendations for government, community organisations and policymakers alike.
For peer reviewed publications, see: Research Articles
General practitioners' knowledge of hepatitis C care has increased over time, yet many are unsure wh...
The number of people being cured of hepatitis C has improved since the introduction of direct-acting...
There are currently 11 vaccine candidates for COVID‑19 in clinical trials. Five of the six vaccines ...
Providing hepatitis C treatment in the primary care setting increases both treatment uptake and cure...
Rapid EC: Point-of-care testing for hepatitis C at needle and syringe programs is feasible and accep...
Universal availability of hepatitis C treatment is a critical but insufficient step towards eliminat...
Implementation of a remote consultation pathway facilitates interaction between general practitioner...
Targeted interventions are needed to increase hepatitis C treatment uptake in non- metropolitan area...
Routine testing and prompt treatment uptake can significantly reduce hepatitis C prevalence among HI...
Universal access to hepatitis C medication alone is insufficient to eliminate hepatitis C as a publi...
A Burnet Institute survey undertaken in 2016 showed that although many general practitioners are int...
Hepatitis C incidence appears to be decreasing, but in a cohort of people who inject drugs in Melbou...
People who inject drugs experience high levels of psychological distress and recent assault, intenti...
A systematic review conducted in 2015 demonstrated that – compared to tertiary- based hepatitis C ca...
Reaching the WHO hepatitis C elimination targets in Australia is cost-effective and can be achieved ...
Treating people who inject drugs for hepatitis C with new therapies is cost-effective and could prev...